Loading…

Variability of the Symptoms of Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome during Intermittent Therapy with Rectal Prednisolone Foam for Ulcerative Colitis

We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2...

Full description

Saved in:
Bibliographic Details
Published in:International journal of STD & AIDS 2001-11, Vol.12 (11), p.752-753
Main Authors: Talbot, Martin, Bates, Sylvia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c363t-de981129ab172d526414b8e1a164235ef2a3e637d4117667a7d4e85dc8e3f28f3
cites cdi_FETCH-LOGICAL-c363t-de981129ab172d526414b8e1a164235ef2a3e637d4117667a7d4e85dc8e3f28f3
container_end_page 753
container_issue 11
container_start_page 752
container_title International journal of STD & AIDS
container_volume 12
creator Talbot, Martin
Bates, Sylvia
description We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2 treatment cycles lends further anecdotal support to our hypothesis that treatment of the immune-mediated response in this chronic condition has a beneficial effect upon symptomatic outcome.
doi_str_mv 10.1258/0956462011924137
format article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1258_0956462011924137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1258_0956462011924137</sage_id><sourcerecordid>10.1258_0956462011924137</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-de981129ab172d526414b8e1a164235ef2a3e637d4117667a7d4e85dc8e3f28f3</originalsourceid><addsrcrecordid>eNp1kEFr3DAQhUVpabZp7z0VXXp0o5Fs2T6GpWkCgYY26dWM5XFWwZYWSZuwv6l_MnJ3S6DQ00i8783wHmMfQXwBWTVnoq10qaUAaGUJqn7FVlBXTQGikq_ZapGLrJcn7F2MD0IIrer2LTsBqJq2gXrFfv_CYLG3k0177keeNsR_7udt8nNc_utN8M4aft6jSZTRid8EHxMmm2w8-yvf0PS4DLQu290Q_Ex82AXr7vmVy8bZpkQu8dsNBdzu-ZNNG_6DTPqzkAZno5-8I37hceajD_xuMhlN9pH42k_LtffszYhTpA_HecruLr7eri-L6-_frtbn14VRWqVioBwNZIs91HKopC6h7BsCBF1KVdEoUVEuYigBaq1rzC9qqsE0pEbZjOqUicNek5PGQGO3DXbGsO9AdEvv3b-9Z8ung2W762caXgzHojPw-QhgNDiNAZ2x8YXLW3StZOaKAxfxnroHvwsuR_3_4Wdy-5rY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Variability of the Symptoms of Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome during Intermittent Therapy with Rectal Prednisolone Foam for Ulcerative Colitis</title><source>SAGE</source><creator>Talbot, Martin ; Bates, Sylvia</creator><creatorcontrib>Talbot, Martin ; Bates, Sylvia</creatorcontrib><description>We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2 treatment cycles lends further anecdotal support to our hypothesis that treatment of the immune-mediated response in this chronic condition has a beneficial effect upon symptomatic outcome.</description><identifier>ISSN: 0956-4624</identifier><identifier>EISSN: 1758-1052</identifier><identifier>DOI: 10.1258/0956462011924137</identifier><identifier>PMID: 11589817</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Anti-Inflammatory Agents - administration &amp; dosage ; Anti-Inflammatory Agents - adverse effects ; Anti-Inflammatory Agents - therapeutic use ; Biological and medical sciences ; Chronic Disease ; Colitis, Ulcerative - complications ; Colitis, Ulcerative - drug therapy ; Drug toxicity and drugs side effects treatment ; Glucocorticoids - administration &amp; dosage ; Glucocorticoids - adverse effects ; Glucocorticoids - therapeutic use ; Humans ; Male ; Medical sciences ; Pelvic Pain - complications ; Pelvic Pain - physiopathology ; Pharmacology. Drug treatments ; Prednisolone - administration &amp; dosage ; Prednisolone - adverse effects ; Prednisolone - therapeutic use ; Prostatitis - complications ; Prostatitis - physiopathology ; Rectum ; Self-Examination ; Syndrome ; Toxicity: urogenital system</subject><ispartof>International journal of STD &amp; AIDS, 2001-11, Vol.12 (11), p.752-753</ispartof><rights>2001 SAGE Publications</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-de981129ab172d526414b8e1a164235ef2a3e637d4117667a7d4e85dc8e3f28f3</citedby><cites>FETCH-LOGICAL-c363t-de981129ab172d526414b8e1a164235ef2a3e637d4117667a7d4e85dc8e3f28f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923,79134</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14136732$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11589817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Talbot, Martin</creatorcontrib><creatorcontrib>Bates, Sylvia</creatorcontrib><title>Variability of the Symptoms of Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome during Intermittent Therapy with Rectal Prednisolone Foam for Ulcerative Colitis</title><title>International journal of STD &amp; AIDS</title><addtitle>Int J STD AIDS</addtitle><description>We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2 treatment cycles lends further anecdotal support to our hypothesis that treatment of the immune-mediated response in this chronic condition has a beneficial effect upon symptomatic outcome.</description><subject>Adult</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents - adverse effects</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Colitis, Ulcerative - complications</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Glucocorticoids - administration &amp; dosage</subject><subject>Glucocorticoids - adverse effects</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pelvic Pain - complications</subject><subject>Pelvic Pain - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prednisolone - administration &amp; dosage</subject><subject>Prednisolone - adverse effects</subject><subject>Prednisolone - therapeutic use</subject><subject>Prostatitis - complications</subject><subject>Prostatitis - physiopathology</subject><subject>Rectum</subject><subject>Self-Examination</subject><subject>Syndrome</subject><subject>Toxicity: urogenital system</subject><issn>0956-4624</issn><issn>1758-1052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kEFr3DAQhUVpabZp7z0VXXp0o5Fs2T6GpWkCgYY26dWM5XFWwZYWSZuwv6l_MnJ3S6DQ00i8783wHmMfQXwBWTVnoq10qaUAaGUJqn7FVlBXTQGikq_ZapGLrJcn7F2MD0IIrer2LTsBqJq2gXrFfv_CYLG3k0177keeNsR_7udt8nNc_utN8M4aft6jSZTRid8EHxMmm2w8-yvf0PS4DLQu290Q_Ex82AXr7vmVy8bZpkQu8dsNBdzu-ZNNG_6DTPqzkAZno5-8I37hceajD_xuMhlN9pH42k_LtffszYhTpA_HecruLr7eri-L6-_frtbn14VRWqVioBwNZIs91HKopC6h7BsCBF1KVdEoUVEuYigBaq1rzC9qqsE0pEbZjOqUicNek5PGQGO3DXbGsO9AdEvv3b-9Z8ung2W762caXgzHojPw-QhgNDiNAZ2x8YXLW3StZOaKAxfxnroHvwsuR_3_4Wdy-5rY</recordid><startdate>20011101</startdate><enddate>20011101</enddate><creator>Talbot, Martin</creator><creator>Bates, Sylvia</creator><general>SAGE Publications</general><general>Royal Society of Medicine Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20011101</creationdate><title>Variability of the Symptoms of Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome during Intermittent Therapy with Rectal Prednisolone Foam for Ulcerative Colitis</title><author>Talbot, Martin ; Bates, Sylvia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-de981129ab172d526414b8e1a164235ef2a3e637d4117667a7d4e85dc8e3f28f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents - adverse effects</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Colitis, Ulcerative - complications</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Glucocorticoids - administration &amp; dosage</topic><topic>Glucocorticoids - adverse effects</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pelvic Pain - complications</topic><topic>Pelvic Pain - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prednisolone - administration &amp; dosage</topic><topic>Prednisolone - adverse effects</topic><topic>Prednisolone - therapeutic use</topic><topic>Prostatitis - complications</topic><topic>Prostatitis - physiopathology</topic><topic>Rectum</topic><topic>Self-Examination</topic><topic>Syndrome</topic><topic>Toxicity: urogenital system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Talbot, Martin</creatorcontrib><creatorcontrib>Bates, Sylvia</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>International journal of STD &amp; AIDS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Talbot, Martin</au><au>Bates, Sylvia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variability of the Symptoms of Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome during Intermittent Therapy with Rectal Prednisolone Foam for Ulcerative Colitis</atitle><jtitle>International journal of STD &amp; AIDS</jtitle><addtitle>Int J STD AIDS</addtitle><date>2001-11-01</date><risdate>2001</risdate><volume>12</volume><issue>11</issue><spage>752</spage><epage>753</epage><pages>752-753</pages><issn>0956-4624</issn><eissn>1758-1052</eissn><abstract>We describe the response of symptoms of chronic abacterial prostatitis/chronic pelvic pain syndrome (CAP/PPS) in a man treated with rectal prednisolone for concomitant ulcerative colitis. The temporal relationship of the symptoms of CAP/PPS to starting and stopping the topical corticosteroid over 2 treatment cycles lends further anecdotal support to our hypothesis that treatment of the immune-mediated response in this chronic condition has a beneficial effect upon symptomatic outcome.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>11589817</pmid><doi>10.1258/0956462011924137</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0956-4624
ispartof International journal of STD & AIDS, 2001-11, Vol.12 (11), p.752-753
issn 0956-4624
1758-1052
language eng
recordid cdi_crossref_primary_10_1258_0956462011924137
source SAGE
subjects Adult
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - adverse effects
Anti-Inflammatory Agents - therapeutic use
Biological and medical sciences
Chronic Disease
Colitis, Ulcerative - complications
Colitis, Ulcerative - drug therapy
Drug toxicity and drugs side effects treatment
Glucocorticoids - administration & dosage
Glucocorticoids - adverse effects
Glucocorticoids - therapeutic use
Humans
Male
Medical sciences
Pelvic Pain - complications
Pelvic Pain - physiopathology
Pharmacology. Drug treatments
Prednisolone - administration & dosage
Prednisolone - adverse effects
Prednisolone - therapeutic use
Prostatitis - complications
Prostatitis - physiopathology
Rectum
Self-Examination
Syndrome
Toxicity: urogenital system
title Variability of the Symptoms of Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome during Intermittent Therapy with Rectal Prednisolone Foam for Ulcerative Colitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T14%3A48%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variability%20of%20the%20Symptoms%20of%20Chronic%20Abacterial%20Prostatitis/Chronic%20Pelvic%20Pain%20Syndrome%20during%20Intermittent%20Therapy%20with%20Rectal%20Prednisolone%20Foam%20for%20Ulcerative%20Colitis&rft.jtitle=International%20journal%20of%20STD%20&%20AIDS&rft.au=Talbot,%20Martin&rft.date=2001-11-01&rft.volume=12&rft.issue=11&rft.spage=752&rft.epage=753&rft.pages=752-753&rft.issn=0956-4624&rft.eissn=1758-1052&rft_id=info:doi/10.1258/0956462011924137&rft_dat=%3Csage_cross%3E10.1258_0956462011924137%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c363t-de981129ab172d526414b8e1a164235ef2a3e637d4117667a7d4e85dc8e3f28f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11589817&rft_sage_id=10.1258_0956462011924137&rfr_iscdi=true